Guided Therapeutics To Introduce New Cancer Detection Technology At Medica 2009

 03.11.2009 12:09   medicalnewstoday.com

Guided Therapeutics, Inc. (GT) (Pink Sheets: GTHP) today announced plans to introduce its LightTouch™ non-invasive cancer detection technology at Medica 2009 in Düsseldorf, Germany November 18 - 20, 2009. GT will be showcasing the LightTouch Cervical Neoplasia Detection System in anticipation of a 2010 international launch.

World Cancer

Treating Breast Cancer With Adapted Space-Industry Technology

Researchers at Rush University Medical Center and Argonne National Laboratory are collaborating on a...

Laser-Particle Acceleration Is Expected To Contribute To Future Advances In Modern Cancer Radiotherapy

An international team of physicists at Los Alamos National Laboratory has succeeded in using intense...

What Are The Real Benefits Versus Risks Of Preventative Brain Radiation For Patients With Non-small Cell Lung Cancer?

Patients with non-small cell lung cancer treated with preventative brain radiation (called proph...

Radiation After Surgery Reduces Chance Of Melanoma Returning

High-risk melanoma patients who are treated with radiation after surgery have a significantly lo...

Additional, Specialized Radiation Not Necessary For Some Women After Mastectomy

After mastectomy, breast cancer patients who receive radiation treatment to the lymph nodes located ...

American Society Of Clinical Oncology (ASCO) Statement On Cuts To Cancer Care In 2010 Medicare Physician Fee Schedule

Below is a statement for attribution to ASCO CEO Allen S. Lichter, MD: "Today, CMS issued its ph...

Celldex Therapeutics Presents Positive Clinical Data From Phase 1 Studies Of Antibody-Based Cancer Vaccine Candidate, CDX-1307

Celldex Therapeutics, Inc. (NASDAQ: CLDX) announced positive results from Phase 1 studies of CDX-...

Studies Show Early Promise Of MannKind's Cancer Immunotherapy Program In Melanoma, Prostate Cancer And Other Solid Malignancies

Results of two phase 1 studies demonstrate that the novel, investigational cancer vaccines MKC1106&#...

Imaging Systems From GE Healthcare Spotlight The Possibilities Of Connected Oncology Care At ASTRO 2009

According to the American Cancer Society, more than one million people are diagnosed with cancer eac...

Covidien Receives FDA Approval For Oral Transmucosal Fentanyl Citrate Product

Covidien (NYSE: COV), a leading global provider of healthcare products, announced that its subsidiar...